Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Integra LifeSciences's dural graft matrix granted 510(k) clearance by FDA

Aug. 3, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

Adolor and SmithKline Beecham sign licensing agreement for ADL-2-1294

July 29, 1999

Patient enrollment completed in Anogesic phase III trial

July 27, 1999

IDE granted to Gliatech for ADCON-A

July 22, 1999

Nonsteroidal Rx for atopic dermatitis enters late-stage clinical trials in U.S.

July 13, 1999

Positive results from phase II psoriasis study of hu1124 presented at dermatology meeting

July 8, 1999

Abgenix and Japan Tobacco enter collaboration for ABX-IL-8 development

July 2, 1999

Dusa receives FDA approvable letter for Levulan NDA

June 30, 1999

Preclinical profile suggests that cipamfylline is a promising candidate for atopic dermatitis

June 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...